TCH seal
TCH Laboratory — QMS Dashboard
Tarangnan Community Hospital · Quality Management System integrated with LUIB (read-only)
4
Notices
At a glance: 0 of 100 controlled documents approved (all V0 drafts) · 5 of 11 register indicators computable from this snapshot · visual library: 18 bench cards, 27 infographics, 29 flowcharts.
Snapshot freshness: Snapshot is 0 days old — within the weekly refresh cycle. (File: luib_snapshot.db, dated 2026-10-24 08:42)
Data source: this dashboard reads a snapshot — a copy of a LUIB backup file (see Snapshot freshness above), refreshed weekly. It is NOT the live clinical database and nothing here writes to LUIB. QMS document data is real: parsed from the actual MASTER-DOCUMENT-INDEX and the bundled document copies. All figures are computed live from the snapshot by this page.
Opened from LUIB? This dashboard runs in its own browser tab/window. To return to LUIB, close this tab or switch back to the LUIB window — nothing here writes to LUIB, and closing this page does not affect it.
Home / Documents / LAB-QM-POST-003

LAB-QM-POST-003 — Turnaround Time and STAT Testing Policy

Type: Policy · Version: V0 · Status: DRAFT — UNAPPROVED · Served read-only from the bundled QMS copies. The Drive master is untouched.

Related visual material

fig-01 — STAT specimen prioritization and turnaround time delay notification flowIG-12 — Turnaround Times

Rendered in-browser from the project's Word file LAB-QM-POST-003-turnaround-time-and-stat-testing-policy.docx (policies-docx / forms-docx — the file Junry reviews). Formatting is faithful, not pixel-perfect; the DOCX is the official copy.

1.0 Purpose

To define turnaround times (TAT) for Laboratory tests, establish a uniform STAT test policy and procedure facilitating efficient processing of samples in emergency situations, and describe the plan for notifying clients when result availability will not meet specified times.

2.0 Scope

Applies to all areas and personnel in the Laboratory, and to Medical, Clinical, and Nursing staff receiving, processing, and reporting routine and STAT examinations. Basic ABO/Rh slide typing under Hematology is in scope.

3.0 Definitions

4.0 Responsibility

4.1 Hospital Director

4.2 Pathologist

4.3 Chief Medical Technologist / Laboratory Quality Manager

4.4 Medical Technologists

4.5 Laboratory Aides

4.6 Nursing Personnel and Clinicians

5.0 Policy / Procedure

5.1 Policy Statement

The Laboratory takes all necessary steps to ensure immediate, expeditious performance of tests/services when results are required for the immediate diagnosis and treatment of a seriously ill patient.

Each section defines result TAT for each test; when result availability will not meet the specified time, physicians, nursing units, and clients are notified by electronic message, written notice (memo/cover letter), or telephone (documented on the Technical Delay & TAT Monitoring Log, F-QM-POST-003-A-V0).

STAT requests are limited to cases where the patient requires immediate care — inappropriate STAT use increases TAT for both STAT and non-STAT tests.

5.2 TAT Targets

5.3 STAT Testing

5.3.1 Default STAT Areas

CONFIRMED 2026-08-22. TCH's only default-STAT critical-care area is the Emergency Room — laboratory investigations from the ER are treated as STAT by default unless otherwise instructed. TCH's other wards are non-STAT by default: Medical, OB (Obstetrics), Pediatrics, Isolation, and ITC.

Tests from these non-STAT wards are handled as STAT only when specifically ordered STAT by the requesting physician per Section 5.3.3 below. TCH does not operate an ICU, NICU, dedicated OR, or Hemodialysis Unit.

5.3.2 STAT Test List

The tests/services available on a STAT basis are maintained as a controlled reference list (STAT Test List) approved by the Chief Medical Technologist. Any test not on this list must be approved by the Chief Medical Technologist or designee before being performed as STAT.

5.3.3 Ordering and Collection

STAT tests are ordered by a physician or authorized designee, clearly identified on the request form.

STAT samples are collected, labeled, and delivered to the Laboratory per Specimen Collection Policy, with the following additional STAT-identification measures: a "STAT" colored sticker label (e.g. red) affixed to the sample and/or the word "STAT" legibly written with a highlighter/marker, positioned so as not to obstruct any barcode or required information.

5.3.4 Result Notification

Once a STAT result is finalized, the requesting unit is telephonically notified per the results-distribution process in Laboratory Reporting Policy Section 5.3. If the STAT result is also a critical/panic value, it is additionally handled per Reporting Critical Values Policy. The call (date, time, name of person notified) is documented on the Technical Delay & TAT Monitoring Log (F-QM-POST-003-A-V0).

5.3.5 Shortened TAT for Critical Clinical Situations

When the patient's clinical condition is deemed critical by the attending/requesting physician, the TAT may be shortened below the standard STAT TAT (see Section 5.2 above for standard TAT targets), provided the requesting physician or designee makes prior telephone notification to the Laboratory before sending the specimen.

5.4 Delay Notification Process

Figure 1 — STAT specimen prioritization and turnaround time delay notification flow

5.5 Add-On, Verbal, and Standing Orders

5.6 Reflex Testing

Reflex testing (performed automatically based on certain results, e.g. confirmation of a positive result) is limited to standard medical practice; physicians may contact the Laboratory for reflex-testing information or to request the initial test without the reflex component.

5.7 Test Cancellation and Recollect Requests

Cancellation requests are accepted before test set-up at no charge; requests after set-up cannot be honored. Specimens are assessed for integrity before testing; a recollect is requested if the specimen is hemolyzed, clotted, of insufficient volume, mislabeled/unlabeled, the wrong specimen type, or otherwise compromised (see Specimen Collection Policy Section 5.6).

Processing of a suboptimal or irreplaceable specimen is approved at the discretion of the Chief Medical Technologist.

5.8 Repeat Testing

If the validity of a result is questioned relative to clinical findings, the Laboratory repeats the assay upon notification/request from the technical section where testing was performed.

5.9 Specimen Storage for Add-On Testing

Sera, urine, and body-fluid specimens of sufficient volume are refrigerated and stored per Laboratory Retention Schedule Policy, and remain available for add-on testing during the applicable retention window.

6.0 Records

Form NumberForm Title
F-QM-POST-003-A-V0Technical Delay & TAT Monitoring Log

The Technical Delay & TAT Monitoring Log is shared with Laboratory Reporting Policy. The STAT Test List is maintained as an approved controlled clinical reference document under Document Control Policy.

7.0 References

Companion policies:

Controlled visual annex: